(Press-News.org) Many cancer therapies function by activating proteins like Caspase-3 (CASP3) that promote cell death. Several forms of cancer develop resistance to these drugs by down regulating CASP3 through an unknown mechanism. In the absence of CASP3, tumor cells produce another cell death promoting protein CASP7, but it is rendered inactive by the X-linked inhibitor of apoptosis protein (XIAP). In this issue of the Journal of Clinical Investigation, Po-Huang Liang and colleagues at Academia Sinica identify a compound (I-Lys) that disrupts the interaction between CASP7 and XIAP. Release of CASP7 from this complex in drug resistant cancer cells activated cell death and reduced malignancies. Furthermore, no adverse side effects were observed in non-tumor cells treated with the drug. In the accompanying commentary, Gregory Gores from the Mayo Clinic explains that these results are promising for combatting drug resistant cancers, but more work needs to be done to establish if I-Lys will be safe and beneficial for human use.
###
TITLE:
Targeting the XIAP/caspase-7 complex selectively kills caspase-3–deficient malignancies
AUTHOR CONTACT:
Po-Huang Liang
Academia Sinica, Taiwan R.O.C., Taipei, , TWN
Phone: +886-2-3366-4069; E-mail: phliang@gate.sinica.edu.tw
View this article at: http://www.jci.org/articles/view/67951?key=e86860a6dfda17980263
ACCOMPANYING COMMENTARY
TITLE:
Unshackling caspase-7 for cancer therapy
AUTHOR CONTACT:
Gregory J Gores
Mayo Clinic, Rochester, MN, USA
Phone: 507-284-0686; Fax: 507-284-0762; E-mail: gores.gregory@mayo.edu
View this article at: http://www.jci.org/articles/view/71440?key=31dca5188081bce3f0ca END
A strategy for combating drug-resistant cancers
2013-08-27
ELSE PRESS RELEASES FROM THIS DATE:
Protease inhibitor resistance involves multiple stages of the HIV-1 life cycle
2013-08-27
HIV-1 protease inhibitors are very effective antiviral drugs. These drugs target HIV-1 proteases, which are required for viral replication. Despite the success of protease inhibitors for suppressing HIV-1, some patients do not respond to protease inhibitor therapy. For most patients, the lack of response is not due to mutation of the HIV-1 protease. In this issue of the Journal of Clinical Investigation, Robert Silcano and colleagues at Johns Hopkins University identify the effects of protease inhibitors on different stages of viral replication. The authors found that protease ...
Origin of a hereditary east Texas bleeding disorder
2013-08-27
A severe hereditary bleeding disorder was described in a large family from east Texas in 2001. The affected family members routinely had bruising, nosebleeds, massive blood loss following injury or surgery, and often required blood transfusions. Routine tests for functional components of the blood coagulation pathway did not reveal any obvious defects. Genomic sequencing revealed a mutation in the gene encoding coagulation factor 5 (FV), but it was not considered to contribute to disease, since clotting assays were normal. In this issue of the Journal of Clinical Investigation, ...
Scientists prevent preterm birth caused by gene-environment interactions
2013-08-27
CINCINNATI – New research in the Journal of Clinical Investigation provides evidence that gene-environment interactions are a major contributor to preterm birth and that using a combinatory treatment strategy can prevent preterm delivery in a mouse model.
In findings posted online Aug. 27, scientists from Cincinnati Children's Hospital Medical Center say their study provides important new insights into a major global health problem – one that remains stubbornly persistent in the United States. Preterm birth causes more than 1 million deaths a year and can leave premature ...
Study finds tumor suppressor may actually fuel aggressive leukemia
2013-08-27
CINCINNATI – New research in the Journal of Clinical Investigation suggests that blocking a protein normally credited with suppressing leukemia may be a promising therapeutic strategy for an aggressive form of the disease called acute myeloid leukemia (AML).
Researchers from Cincinnati Children's Hospital Medical Center report their results in a study posted online Aug. 27 by the journal.
The protein scientists targeted is a transcription factor known as RUNX1, which also plays an important role in helping regulate the normal development of blood cells. The researchers ...
Study identifies molecular process behind form of non-syndromic deafness
2013-08-27
CINCINNATI – Researchers identify an underlying molecular process that causes a genetic form of non-syndromic deafness in a new study that also suggests affected families may be at risk of damage to other organs.
A multi-national research team led by scientists at Cincinnati Children's Hospital Medical Center report their findings in a study posted online Aug. 27 by the Journal of Clinical Investigation. The research opens the door to finding possible treatments for the condition (called DFNB49 non-syndromic hearing loss) and points to possible cellular damage in other ...
Personalized AF management needed to close mortality gap
2013-08-27
Amsterdam, The Netherlands – Tuesday 27 August 2013: Personalised management is the only way to close the mortality gap for patients with atrial fibrillation (AF), according to an ESC consensus paper presented at ESC Congress 2013 by Professor Paulus Kirchhof (UK).
The Atrial Fibrillation competence NETwork (AFNET) and European Heart Rhythm Association (EHRA) consensus paper is published online in the European Journal of Pacing, Arrhythmias, and Cardiac Electrophysiology (EP-Europace)1 and presented during the ESC Congress session on personalised cardiology.
Professor ...
A genetic treasure hunting in sorghum may benefit crop improvement
2013-08-27
August 27, 2013, Shenzhen, China - A consortium of researchers from The University of Queensland, the Queensland Department of Agriculture, Fisheries and Forestry (DAFF Qld) and BGI has discovered that sorghum, a drought-tolerant African crop, holds vastly more genetic variation than previously reported. This study published in Nature Communications today provides an invaluable resource for the genetic improvement of sorghum and other grass species.
Sorghum is not only a food and feed cereal crop, but also can be used as the basis of biofuel. Its resistance to heat and ...
Novel approach to gene regulation can activate multiple genes simultaneously
2013-08-27
CAMBRIDGE, Mass. (August 27, 2013) – By creating a powerful new gene regulation system called CRISPR-on, Whitehead Institute researchers now have the ability to increase the expression of multiple genes simultaneously and precisely manipulate each gene's expression level. The system is effective in both mouse and human cells as well as in mouse embryos.
"CRISPR-on is a tool that will be very useful for studying many biological processes, particularly for studying gene functions and gene networks," says Whitehead Founding Member Rudolf Jaenisch. "In contrast to RNA interference, ...
European hunter-gatherers owned pigs as early as 4600BC
2013-08-27
European hunter-gatherers acquired domesticated pigs from nearby farmers as early as 4600BC, according to new evidence.
The international team of scientists, including researchers at Durham and Aberdeen universities, showed there was interaction between the hunter-gatherer and farming communities and a 'sharing' of animals and knowledge. The interaction between the two groups eventually led to the hunter-gatherers incorporating farming and breeding of livestock into their culture, say the scientists.
The research, published in Nature Communications today (27 August), ...
Long-term memory in the cortex
2013-08-27
'Where' and 'how' memories are encoded in a nervous system is one of the most challenging questions in biological research. The formation and recall of associative memories is essential for an independent life. The hippocampus has long been considered a centre in the brain for the long-term storage of spatial associations. Now, Mazahir T. Hasan at the Max Planck Institute for Medical Research and José Maria Delgado-Garcìa at the University Pablo de Olavide of Seville, Spain, were able to provide first experimental evidence that a specific form of memory associations is ...